OMDANasdaqServices-Health ServicesFiscal year ends December 31
Omada Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$18.06+0.43 (+2.44%)
Close on Oct 19, 2026
- Market cap
- $1.15B
- P/E (TTM)
- –
- Dividend yield
- –
Omada Health, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Services | $284.87M | $261.14M | $241.04M | $214.83M | $193.99M | $175.38M | $157.79M | 92.0% | +46.8% |
| Hardware | $24.89M | $22.15M | $19.17M | $17.51M | $15.84M | $14.29M | $12.01M | 8.0% | +57.1% |
By region
From the segment and revenue-disaggregation notes of Omada Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.